🌎ID&E:RegulatoryoversightprotectsfairnessPro:Expandstreatmentoptions✅Pro:Encouragesefficiency“Innovation”✅Pro:Expandstreatmentoptions🌎ID&E:Increasesaccess tolife-savingdevicesCon:ReducescompetitionEdwardsLifesciencesHeartWare❌Con:Risk ofmarketmonopoly🌎ID&E:May reduceequitableaccess ifcosts rise✅Pro:Lowerslong-termcostsID&E: Riskof bias intechnologyadoptionCon:Potential jobloss insmaller firmsPro:PromotesfasterdevelopmentID&E: Mayreduceequitableaccess ifcosts rise🌎ID&E:Could createglobaldisparities“CaseStudyMentioned”Con: StiflessmallercompetitorsPro:Lowerslong-termcosts❌Con:AntitrustchallengesID&E: Couldcreateglobaldisparities“Antitrust”❌Con:Stiflessmallercompetitors✅Pro:Createscompetitiveadvantage✅Pro:Drivesinnovation❌Con: Canlimitinnovation (ifmonopolized)ID&E:ImpactsaffordabilityforunderservedpopulationsID&E:Opportunityto designfor inclusion❌Con:Reducescompetition“CaseStudyMentioned”Pro:Createscompetitiveadvantage❌Con:Raisescost forconsumersCon: Riskof marketmonopolyCon:Antitrustchallenges🌎ID&E:Opportunityto designfor inclusion❌Con:Potential jobloss insmaller firmsTAVR-ARdevice🌎ID&E:Risk of biasintechnologyadoptionPro:DrivesinnovationID&E:Regulatoryoversightprotectsfairness✅Pro:PromotesfasterdevelopmentID&E:Increasesaccess tolife-savingdevicesCon: Canlimitinnovation (ifmonopolized)Pro:Improvespatientoutcomes“Innovation”ThoratecPro:Encouragesefficiency🌎ID&E:Impactsaffordability forunderservedpopulations✅Pro:Improvespatientoutcomes“Antitrust”Con:Raisescost forconsumersJenaValve🌎ID&E:RegulatoryoversightprotectsfairnessPro:Expandstreatmentoptions✅Pro:Encouragesefficiency“Innovation”✅Pro:Expandstreatmentoptions🌎ID&E:Increasesaccess tolife-savingdevicesCon:ReducescompetitionEdwardsLifesciencesHeartWare❌Con:Risk ofmarketmonopoly🌎ID&E:May reduceequitableaccess ifcosts rise✅Pro:Lowerslong-termcostsID&E: Riskof bias intechnologyadoptionCon:Potential jobloss insmaller firmsPro:PromotesfasterdevelopmentID&E: Mayreduceequitableaccess ifcosts rise🌎ID&E:Could createglobaldisparities“CaseStudyMentioned”Con: StiflessmallercompetitorsPro:Lowerslong-termcosts❌Con:AntitrustchallengesID&E: Couldcreateglobaldisparities“Antitrust”❌Con:Stiflessmallercompetitors✅Pro:Createscompetitiveadvantage✅Pro:Drivesinnovation❌Con: Canlimitinnovation (ifmonopolized)ID&E:ImpactsaffordabilityforunderservedpopulationsID&E:Opportunityto designfor inclusion❌Con:Reducescompetition“CaseStudyMentioned”Pro:Createscompetitiveadvantage❌Con:Raisescost forconsumersCon: Riskof marketmonopolyCon:Antitrustchallenges🌎ID&E:Opportunityto designfor inclusion❌Con:Potential jobloss insmaller firmsTAVR-ARdevice🌎ID&E:Risk of biasintechnologyadoptionPro:DrivesinnovationID&E:Regulatoryoversightprotectsfairness✅Pro:PromotesfasterdevelopmentID&E:Increasesaccess tolife-savingdevicesCon: Canlimitinnovation (ifmonopolized)Pro:Improvespatientoutcomes“Innovation”ThoratecPro:Encouragesefficiency🌎ID&E:Impactsaffordability forunderservedpopulations✅Pro:Improvespatientoutcomes“Antitrust”Con:Raisescost forconsumersJenaValve

Competitive Technology - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
  1. 🌎ID&E: Regulatory oversight protects fairness
  2. Pro: Expands treatment options
  3. ✅Pro: Encourages efficiency
  4. “Innovation”
  5. ✅Pro: Expands treatment options
  6. 🌎ID&E: Increases access to life-saving devices
  7. Con: Reduces competition
  8. Edwards Lifesciences
  9. HeartWare
  10. ❌Con: Risk of market monopoly
  11. 🌎ID&E: May reduce equitable access if costs rise
  12. ✅Pro: Lowers long-term costs
  13. ID&E: Risk of bias in technology adoption
  14. Con: Potential job loss in smaller firms
  15. Pro: Promotes faster development
  16. ID&E: May reduce equitable access if costs rise
  17. 🌎ID&E: Could create global disparities
  18. “Case Study Mentioned”
  19. Con: Stifles smaller competitors
  20. Pro: Lowers long-term costs
  21. ❌Con: Antitrust challenges
  22. ID&E: Could create global disparities
  23. “Antitrust”
  24. ❌Con: Stifles smaller competitors
  25. ✅Pro: Creates competitive advantage
  26. ✅Pro: Drives innovation
  27. ❌Con: Can limit innovation (if monopolized)
  28. ID&E:Impacts affordability for underserved populations
  29. ID&E: Opportunity to design for inclusion
  30. ❌Con: Reduces competition
  31. “Case Study Mentioned”
  32. Pro: Creates competitive advantage
  33. ❌Con: Raises cost for consumers
  34. Con: Risk of market monopoly
  35. Con: Antitrust challenges
  36. 🌎ID&E: Opportunity to design for inclusion
  37. ❌Con: Potential job loss in smaller firms
  38. TAVR-AR device
  39. 🌎ID&E: Risk of bias in technology adoption
  40. Pro: Drives innovation
  41. ID&E: Regulatory oversight protects fairness
  42. ✅Pro: Promotes faster development
  43. ID&E: Increases access to life-saving devices
  44. Con: Can limit innovation (if monopolized)
  45. Pro: Improves patient outcomes
  46. “Innovation”
  47. Thoratec
  48. Pro: Encourages efficiency
  49. 🌎ID&E:Impacts affordability for underserved populations
  50. ✅Pro: Improves patient outcomes
  51. “Antitrust”
  52. Con: Raises cost for consumers
  53. JenaValve